Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: transfer from cath lab s/p stent placement major surgical or invasive procedure: cardiac catheterization with cypher stent placement to lcx. history of present illness: hpi: 82 year old female with a pmh of essential thrombocytosis (et), increased lipids (on no medications), borderline htn and recently started on celebrex for arthritis who presents with approx. 12 hours of nausea, vomiting and malaise. the patient states that at midnight on , she became nauseated with intermittent right sided discomfort from her head to her chest with diaphoresis and sob. she awoke this am feeling ill and diaphoretic. she vomited this am as well and then came to the ed. of note, four days pta she was re-started on hydroxyurea for her ongoing et after several months of not taking it. she was recently found to have a platelet count of 1.3 million and instructed to restart. . at , given asa, iv heparin, iv nitro, lipitor 80mg, lopressor 2.5iv x 2, labs were as follows: hct 42.2, plt 1394 bun 20 cr 1.3 k 4.5 inr 2.75 ekg showed nsr@75, nl pr, rbbb, inferolat. st elevations in ii, iii, avf and v4-8 with reciprocal changes. she was then transferred to where she was taken to the cath lab and found to have 80% stenosis of her om2 which was then stented with a cypher stent. normal filling pressures. hemodynamically stable throughout. ekg changes resolved. given plavix 300 x1. she has remained asymptomatic since with no cp, sob, n or v. past medical history: et; constipation; hypothyroidism; arthritis; htn; s/p cataract surgery; elev. cholesterol social history: lives alone; works as assistant; widowed; no children family history: one brother had a bypass and s/p mi age 71; another brother died of mi at unknown age physical exam: pe: vitals 96.5 65 12 160/75 122 pounds 5'0" heent: perrla, eomi, mmm, no exudates, bilat post cataract changes neck: supple, no lad cv: rrr, no m/r/g s1, s2 7cm jvp; 1+ peripheral pulses lung: cta bilat. abd: soft, nt, nd, bsna, no hsm, no masses ext: no c/c/e pertinent results: data(osh) hct 42.2, plt 1394 bun 20 cr 1.3 k 4.5 inr 2.75 ekg showed nsr@75, nl pr, rbbb, inferolat. st elevations in ii, iii, avf and v4-8 with reciprocal changes. . data (): wbc 8.8 hct 39.9 plt 1527 82.5%p 14.6%l 1%m 1%e inr 2.2 ptt >150 na 139 k 4.6 cl 99 bicarb 23 bun 21 cr 1.3 gluc 139 cardiac cath 9/7/5: pcw 16; ra 13/11 (8); ao 118/61 (83); rv 25/8; co 4.53/ci 2.9; 80% stenosis of lcx om2 --> cypher to lcx. brief hospital course: ms. is an 82 year old woman with pmh htn, elev. lipids, and essential thrombocytosis (chronic ongoing)admitted with stemi secondary to an occluded lcx, likely in the setting of increased platelets due to her underlying essential thrombocytosis resulting in pro-thrombotic state. . plan: 1) stemi- likely inferolateral mi secondary to lcx occlusion (om2) in the setting of a hypercoagulable state due to et. s/p cypher stent to om2 placed (see details below). hemodynamically stable after intervention with resolved ekg changes. - integrillin x 18h followed procedure - serial cardiac enzymes trended down 296 --> 149 with mb fractions 22 on day of stemi trending to 7, troponins trended from 0.62 to 0.44. - echo one day post intervention revealed the following: 1. mild symmetric left ventricular hypertrophy. the left ventricular cavity size is normal. regional left ventricular wall motion is normal. left ventricular systolic function is hyperdynamic (ef>75%). 2. the aortic valve leaflets (3) are mildly thickened. there is a minimally increased gradient consistent with minimal aortic valve stenosis. mild (1+) aortic regurgitation is seen. 3. the mitral valve leaflets are mildly thickened. trivial mitral regurgitation is seen. - plavix 150mg qd (confirmed with heme)to be continued at home. - cont. asa at home - started lopressor 12.5 , and titrated up to 25 . tolerated well. will continue as outpatient - lipitor 80 daily will continue as outpatient. . 2) essential thrombocytosis (ongoing) - dr. consulted (heme-onc)for platelets on admission >1.3 million. he is familiar with this patient and has seen her in clinic in the past. - hydrea 1g x2 administered on day number one. pt. had phoresis catheter placed to her left ij on day #2 and then underwent plasmaphoresis with subsequent drop in platelet count to approx. 400,000. restarted one day post procedure on hydrea 500mg . this is the dose on which she will be discharged for continuation at home. she will follow with dr. in one month with a platelet check in a week at and a visit with her pcp in the coming week as well. . 3) htn - held spironolactone and added beta blocker s/p mi. will continue this as outpatient (metoprolol 25mg ). - pcp can consider added ace inhibitor as outpatient. - on day #4, had decreased hct to 27 from 31. transfured one unit prbcs given recent mi. hct stable on day of discharge at 33.9. will need follow up hct check this week with pcp. . 4) hypothyroid - cont. levothyroxin. . 5) arthritis: tylenol medications on admission: hydroxyurea 500mg (restarted 3 days ago); celebrex 200mg po daily (started 3 days ago); levothyroxine 75 mcg daily; spironolactone 25mg daily. discharge medications: 1. clopidogrel 75 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*5* 2. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*5* 3. levothyroxine sodium 75 mcg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*5* 4. allopurinol 100 mg tablet sig: one (1) tablet po every other day (every other day). disp:*15 tablet(s)* refills:*5* 5. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*5* 6. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*5* 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 8. hydroxyurea 500 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* discharge disposition: home with service facility: vna discharge diagnosis: stemi (s/p cypher stent to lcx) discharge condition: stable discharge instructions: pls take all meds as prescribed. follow up as indicated below. please seek medical care immediately if you develop chest, arm, or jaw pain. pls call if you become sweaty or dizzy or if any new signs or symptoms should develop. followup instructions: on for platelet count . dr. in 4 weeks. pls call hospital for appointment (. . dr. (one place) on at 2:15 . home pt this week procedure: venous catheterization, not elsewhere classified combined right and left heart cardiac catheterization coronary arteriography using two catheters injection or infusion of platelet inhibitor insertion of drug-eluting coronary artery stent(s) therapeutic plateletpheresis diagnoses: coronary atherosclerosis of native coronary artery acute myocardial infarction of other inferior wall, initial episode of care unspecified diseases of blood and blood-forming organs 

Answer: The patient is high likely exposed to